Related references
Note: Only part of the references are listed.The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting
Eloisa Romano et al.
CURRENT MOLECULAR MEDICINE (2022)
Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients
Michele Colaci et al.
CLINICAL RHEUMATOLOGY (2021)
Dissecting the Cellular Mechanism of Prostacyclin Analog Iloprost in Reversing Vascular Dysfunction in Scleroderma
Pei-Suen Tsou et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis
Elena Andreucci et al.
RHEUMATOLOGY (2021)
Tyrosine kinases in the pathogenesis of tissue fibrosis in systemic sclerosis and potential therapeutic role of their inhibition
Fabian A. Mendoza et al.
TRANSLATIONAL RESEARCH (2021)
Vascular smooth muscle cells in atherosclerosis: time for a re-assessment
Mandy O. J. Grootaert et al.
CARDIOVASCULAR RESEARCH (2021)
Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: much caution is warranted
Marco Mura
PULMONARY PHARMACOLOGY & THERAPEUTICS (2021)
High-resolution 3D imaging uncovers organ-specific vascular control of tissue aging
Junyu Chen et al.
SCIENCE ADVANCES (2021)
Vascular endothelial cell specification in health and disease
Corina Marziano et al.
ANGIOGENESIS (2021)
X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc)
Christina Bergmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Cardiac involvement in systemic sclerosis: Getting to the heart of the matter
Cosimo Bruni et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2021)
The microbiome and systemic sclerosis: A review of current evidence
Tze Chin Tan et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2021)
Endothelial-to-mesenchymal transition in systemic sclerosis
P. Di Benedetto et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)
Nintedanib: A Review
Yvette N. Lamb
DRUGS (2021)
New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine
Alain Lescoat et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)
The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension
Ines Roger et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Renal dysfunction in systemic sclerosis beyond scleroderma renal crisis
George Iliopoulos et al.
RHEUMATOLOGY INTERNATIONAL (2021)
Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement
Giacomo De Luca et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients
Barbara Ruaro et al.
PHARMACEUTICALS (2021)
New insights into the Hippo/YAP pathway in idiopathic pulmonary fibrosis
Mingyao Sun et al.
PHARMACOLOGICAL RESEARCH (2021)
Scleroderma renal crisis: Case reports and update on critical issues
Elisabetta Zanatta et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2021)
An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years
Corrado Campochiaro et al.
ARTHRITIS RESEARCH & THERAPY (2021)
Notch-ing up knowledge on molecular mechanisms of skin fibrosis: focus on the multifaceted Notch signalling pathway
Angelo Giuseppe Condorelli et al.
JOURNAL OF BIOMEDICAL SCIENCE (2021)
A Review of Pirfenidone as an Anti-Fibrotic in Idiopathic Pulmonary Fibrosis and Its Probable Role in Other Diseases
Parth Shah et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
The multifaceted problem of pulmonary arterial hypertension in systemic sclerosis
Cosimo Bruni et al.
LANCET RHEUMATOLOGY (2021)
Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis
Alina Soare et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Pathogenesis of atherosclerosis in the tunica intima, media, and adventitia of coronary arteries: An updated review
Aleksandra Milutinovic et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2020)
Hepatocyte Growth Factor Attenuates the Development of TGF-beta 1-Induced EndMT through Down-regulating the Notch Signaling
Ruiping Yang et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2020)
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial
Dinesh Khanna et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Pericyte-myofibroblast transition in the human lung
Miki Yamaguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Rapamycin promotes endothelial-mesenchymal transition during stress-induced premature senescence through the activation of autophagy
Norihiko Sasaki et al.
CELL COMMUNICATION AND SIGNALING (2020)
JAK Inhibitors: Prospects in Connective Tissue Diseases
Hanxiao You et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
Promotion of Myofibroblast Differentiation and Tissue Fibrosis by the Leukotriene B4-Leukotriene B4 Receptor Axis in Systemic Sclerosis
Minrui Liang et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition
Min Yu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis
Robert Spiera et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Metabolism of vascular smooth muscle cells in vascular diseases
Jia Shi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope
Monique Hinchcliff et al.
CURRENT RHEUMATOLOGY REPORTS (2020)
Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma-like Vasculopathy in KLF5+/-;Fli-1+/- Mice
Kouki Nakamura et al.
ARTHRITIS & RHEUMATOLOGY (2020)
The Canonical Wnt Pathway as a Key Regulator in Liver Development, Differentiation and Homeostatic Renewal
Sebastian L. Wild et al.
GENES (2020)
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
Dinesh Khanna et al.
LANCET RESPIRATORY MEDICINE (2020)
The Pathogenesis of Systemic Sclerosis: An Understanding Based on a Common Pathologic Cascade across Multiple Organs and Additional Organ-Specific Pathologies
Yoshihide Asano
JOURNAL OF CLINICAL MEDICINE (2020)
Crosstalk of Hedgehog and mTORC1 Pathways
Lasse Jonsgaard Larsen et al.
CELLS (2020)
Role of Vascular Smooth Muscle Cell Plasticity and Interactions in Vessel Wall Inflammation
Vitaly Sorokin et al.
FRONTIERS IN IMMUNOLOGY (2020)
The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis
Irene Rosa et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2020)
The role of the oncostatin M/OSM receptor β axis in activating dermal microvascular endothelial cells in systemic sclerosis
G. Marden et al.
ARTHRITIS RESEARCH & THERAPY (2020)
The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wenxia Wang et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2020)
Research advances in pericyte function and their roles in diseases
Zi-Sen Zhang et al.
CHINESE JOURNAL OF TRAUMATOLOGY (2020)
Microvascular involvement in systemic sclerosis and systemic lupus erythematosus
Didem Saygin et al.
MICROCIRCULATION (2019)
The therapeutic potential of targeting the endothelial-to-mesenchymal transition
Shirley Man et al.
ANGIOGENESIS (2019)
The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis
Yosuke Kanno
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis
Benjamin Korman
TRANSLATIONAL RESEARCH (2019)
Systemic Sclerosis Pathogenesis and Emerging Therapies, beyond the Fibroblast
Andrea Sierra-Sepulveda et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis
Adi Mor et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Macrophages Guard Endothelial Lineage by Hindering Endothelial-to-Mesenchymal Transition: Implications for the Pathogenesis of Systemic Sclerosis
Pier Andrea Nicolosi et al.
JOURNAL OF IMMUNOLOGY (2019)
5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma
Dylan J. Kahl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Klotho Inhibits Unilateral Ureteral Obstruction-Induced Endothelial-to-Mesenchymal Transition via TGF-β1/Smad2/Snail1 Signaling in Mice
Shasha Li et al.
FRONTIERS IN PHARMACOLOGY (2019)
Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis
Robert C. Wirka et al.
NATURE MEDICINE (2019)
Nintedanib ameliorates experimental pulmonary arterial hypertension via inhibition of endothelial mesenchymal transition and smooth muscle cell proliferation
Takeo Tsutsumi et al.
PLOS ONE (2019)
Endothelial-to-mesenchymal transition: Pathogenesis and therapeutic targets for chronic pulmonary and vascular diseases
Xuexin Lu et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis
Andrew J. Haak et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Caveolin-1 as a critical component in the pathogenesis of lung fibrosis of different etiology: Evidences and mechanisms
Ritu Kulshrestha et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2019)
Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis
Ying Jiang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Protective effect of rapamycin on endothelial-to-mesenchymal transition in HUVECs through the Notch signaling pathway
Dingyuan Tian et al.
VASCULAR PHARMACOLOGY (2019)
Cis-activation in the Notch signaling pathway
Nagarajan Nandagopal et al.
ELIFE (2019)
Rationally-based therapeutic disease modification in systemic sclerosis: Novel strategies
Yoshihide Asano et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
Notch1 promotes the pericyte-myofibroblast transition in idiopathic pulmonary fibrosis through the PDGFR/ROCK1 signal pathway
Yi-Chun Wang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis
Christopher P. Denton et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Smooth muscle cell fate and plasticity in atherosclerosis
Sima Allahverdian et al.
CARDIOVASCULAR RESEARCH (2018)
Anti-fibrotic effects of pirfenidone by interference with the hedgehog signalling pathway in patients with systemic sclerosis-associated interstitial lung disease
Hua Xiao et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2018)
Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis
Tetsuo Toyama et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
STAT3 controls COL1A2 enhancer activation cooperatively with JunB, regulates type I collagen synthesis posttranscriptionally, and is essential for lung myofibroblast differentiation
Ioannis Papaioannou et al.
MOLECULAR BIOLOGY OF THE CELL (2018)
Abrogation of transforming growth factor-β-induced tissue fibrosis in TBRIca Col1a2Cre transgenic mice by the second generation tyrosine kinase inhibitor SKI-606 (Bosutinib)
Peter J. Wermuth et al.
PLOS ONE (2018)
Role of integrin alpha8 in murine model of lung fibrosis
Chi F. Hung et al.
PLOS ONE (2018)
Signaling Mechanisms of Myofibroblastic Activation: Outside-in and Inside-Out
Joshua Zent et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis
Takashi Yamashita et al.
SCIENTIFIC REPORTS (2018)
Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?
Cosimo Bruni et al.
FRONTIERS IN IMMUNOLOGY (2018)
A Potential Link Between Oxidative Stress and Endothelial-to-Mesenchymal Transition in Systemic Sclerosis
Duong Thi Bich Thuan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Characterization of human PDGFR-beta-positive pericytes from IPF and non-IPF lungs
Carole L. Wilson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Unraveling SSc Pathophysiology; The Myofibroblast
Arjan van Caam et al.
FRONTIERS IN IMMUNOLOGY (2018)
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)
Dinesh Khanna et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy
Paola Di Benedetto et al.
ARTHRITIS RESEARCH & THERAPY (2018)
The role of the Hedgehog signaling pathway in cancer: A comprehensive review
Ana Marija Skoda et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2018)
Endothelial-to-mesenchymal transition in cardiovascular diseases: Developmental signaling pathways gone awry
Gonzalo Sanchez-Duffhues et al.
DEVELOPMENTAL DYNAMICS (2018)
Triazole RGD antagonist reverts TGFβ1-induced endothelial-to-mesenchymal transition in endothelial precursor cells
Francesca Bianchini et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors
Miroslava Didiasova et al.
FASEB JOURNAL (2017)
Notch Signaling in Endothelial Cells: Is It the Therapeutic Target for Vascular Neointimal Hyperplasia?
Ding-Yuan Tian et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis
Takashi Yamashita et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82
Robert Lafyatis et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Endothelial cell-specific activation of transforming growth factor-β signaling in mice induces cutaneous, visceral, and microvascular fibrosis
Peter J. Wermuth et al.
LABORATORY INVESTIGATION (2017)
Vascular heterogeneity and specialization in development and disease
Michael Potente et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
Debomita Chakraborty et al.
NATURE COMMUNICATIONS (2017)
Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced pulmonary fibrosis in mice
Qiang Fu et al.
ONCOTARGET (2017)
Novel Mechanism of the Pericyte-Myofibroblast Transition in Renal Interstitial Fibrosis: Core Fucosylation Regulation
Nan Wang et al.
SCIENTIFIC REPORTS (2017)
Agnoistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cell Function In Vitro
Silvia Svegliati et al.
FRONTIERS IN IMMUNOLOGY (2017)
Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities
John Varga et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2017)
Deriving vascular smooth muscle cells from mesenchymal stromal cells: Evolving differentiation strategies and current understanding of their mechanisms
Xiaoqing Zhang et al.
BIOMATERIALS (2017)
Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension
Jerome Avouac et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Adenosine A2a Receptor Blockade Diminishes Wnt/β-Catenin Signaling in a Murine Model of Bleomycin-Induced Dermal Fibrosis
Jin Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Anti-connective tissue growth factor (CTGF/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis
Katsunari Makino et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis
Mirko Manetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma
Kim M. Hutchings et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells
Celestina Mazzotta et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Jingang Huang et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease
Fabian A. Mendoza et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
Nadira Ruzehaji et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
The role of PDGF-B/TGF-β1/neprilysin network in regulating endothelial-to-mesenchymal transition in pulmonary artery remodeling
Shasha Song et al.
CELLULAR SIGNALLING (2016)
STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation
Mesias Pedroza et al.
FASEB JOURNAL (2016)
Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells
Tetsuo Toyama et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis
Francesco Ursini et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis Overexpress Activated ADAM12 and Are Involved in Myofibroblast Transdifferentiation and Development of Fibrosis
Paola Cipriani et al.
JOURNAL OF RHEUMATOLOGY (2016)
An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial
Dinesh Khanna et al.
JOURNAL OF RHEUMATOLOGY (2016)
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Dinesh Khanna et al.
LANCET (2016)
Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
Sergio A. Jimenez et al.
MATRIX BIOLOGY (2016)
Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis
Bjoern Hegner et al.
PLOS ONE (2016)
Stimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1
Peter J. Wermuth et al.
PLOS ONE (2016)
Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis
Siri T. Lehtonen et al.
RESPIRATORY RESEARCH (2016)
The isolation and characterization of systemic sclerosis vascular smooth muscle cells: enhanced proliferation and apoptosis resistance
Nezam Altorok et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2016)
Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study
Claudio Corallo et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension
Robert B. Good et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Protective Effect of Spironolactone on Endothelial-to-Mesenchymal Transition in HUVECs via Notch Pathway
Xiao Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway
Mengguo Liu et al.
CLINICS (2015)
Origin of fibrosing cells in systemic sclerosis
Sarah Ebmeier et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Lutz Wollin et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Fli1 deficiency and beyond: a unique pathway linking peripheral vasculopathy and dermal fibrosis in systemic sclerosis
Mirko Manetti
EXPERIMENTAL DERMATOLOGY (2015)
The complex mural cell: Pericyte function in health and disease
Christian G. M. van Dijk et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
Lisa M. Rice et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist
Paola Cipriani et al.
JOURNAL OF RHEUMATOLOGY (2015)
Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition
Sen Shi et al.
KIDNEY INTERNATIONAL (2015)
Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis
Ryosuke Saigusa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Scleroderma renal crisis
Nilanjana Bose et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Macro- and microvascular disease in systemic sclerosis
Niloufar Kavian et al.
VASCULAR PHARMACOLOGY (2015)
Rapamycin Protects from Type-I Peritoneal Membrane Failure Inhibiting the Angiogenesis, Lymphangiogenesis, and Endo-MT
Guadalupe Tirma Gonzalez-Mateo et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Fibrosis, Vascular Activation, and Immune Abnormalities Resembling Systemic Sclerosis in Bleomycin-Treated Fli-1-Haploinsufficient Mice
Takashi Taniguchi et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Signaling in fibrosis: TGF-beta, wNT, and YAP/TAZ converge
Bram Piersma et al.
FRONTIERS IN MEDICINE (2015)
Role of endothelin-1 in the skin fibrosis of systemic sclerosis
J. Jing et al.
EUROPEAN CYTOKINE NETWORK (2015)
Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
Mirko Manetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability
Alfiya Distler et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature
Clodoveo Ferri et al.
AUTOIMMUNITY REVIEWS (2014)
Role of Wnt Signaling in Tissue Fibrosis, Lessons from Skeletal Muscle and Kidney
P. Cisternas et al.
CURRENT MOLECULAR MEDICINE (2014)
Mortality in systemic sclerosis: lessons learned from population-based and observational cohort studies
Mandana Nikpour et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts
Enrico Conte et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Constitutively active Notch1 signaling promotes endothelial-mesenchymal transition in a conditional transgenic mouse model
Ju Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-β (TGF-β) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein
Steven O'Reilly et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner
Alexander Birbrair et al.
STEM CELL RESEARCH & THERAPY (2014)
Cardiac manifestations in systemic sclerosis
Sevdalina Lambova
WORLD JOURNAL OF CARDIOLOGY (2014)
Targeting the Myofibroblast Genetic Switch: Inhibitors of Myocardin-Related Transcription Factor/Serum Response Factor-Regulated Gene Transcription Prevent Fibrosis in a Murine Model of Skin Injury
Andrew J. Haak et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis
Lutz Wollin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Caveolin-1 Deficiency Induces Spontaneous Endothelial-to-Mesenchymal Transition in Murine Pulmonary Endothelial Cells in Vitro
Zhaodong Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Role of Lung Pericytes and Resident Fibroblasts in the Pathogenesis of Pulmonary Fibrosis
Chi Hung et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine
Paola Cipriani et al.
ANGIOGENESIS (2013)
Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
Christian Beyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Review: Evidence That Systemic Sclerosis Is a Vascular Disease
Marco Matucci-Cerinic et al.
ARTHRITIS AND RHEUMATISM (2013)
Immunophenotypical analysis of myofibroblasts and mesenchymal cells in the bleomycin-induced rat scleroderma, with particular reference to their origin
Vetnizah Juniantito et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2013)
Loss of caveolin-1 promotes endothelial-mesenchymal transition during sepsis: A membrane proteomic study
Xiaobo Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
Riociguat for the Treatment of Pulmonary Arterial Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Morphogen Pathways in Systemic Sclerosis
Christian Beyer et al.
CURRENT RHEUMATOLOGY REPORTS (2013)
Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis
Mirko Manetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis
Angelika Horn et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage
Mirko Manetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
JAK-2 as a Novel Mediator of the Profibrotic Effects of Transforming Growth Factor β in Systemic Sclerosis
Clara Dees et al.
ARTHRITIS AND RHEUMATISM (2012)
Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells
Jun Wei et al.
ARTHRITIS AND RHEUMATISM (2012)
Smooth muscle cell phenotypic switching in atherosclerosis
Delphine Gomez et al.
CARDIOVASCULAR RESEARCH (2012)
Lineage tracing and genetic ablation of ADAM12+ perivascular cells identify a major source of profibrotic cells during acute tissue injury
Sophie Dulauroy et al.
NATURE MEDICINE (2012)
Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis
Hao Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
The cannabinoid WIN55,212-2 abrogates dermal fibrosis in scleroderma bleomycin model
Epifania Balistreri et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis
Clara Dees et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Inhibition of Notch Signaling Prevents Experimental Fibrosis and Induces Regression of Established Fibrosis
Clara Dees et al.
ARTHRITIS AND RHEUMATISM (2011)
Protein Kinase Cδ and c-Abl Kinase Are Required for Transforming Growth Factor β Induction of Endothelial-Mesenchymal Transition In Vitro
Zhaodong Li et al.
ARTHRITIS AND RHEUMATISM (2011)
The Origin of the Myofibroblast in Fibroproliferative Vasculopathy: Does the Endothelial Cell Steer the Pathophysiology of Systemic Sclerosis?
Mirko Manetti et al.
ARTHRITIS AND RHEUMATISM (2011)
Overexpression of VEGF165b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Leads to Insufficient Angiogenesis in Patients With Systemic Sclerosis
Mirko Manetti et al.
CIRCULATION RESEARCH (2011)
Notch Initiates the Endothelial-to-Mesenchymal Transition in the Atrioventricular Canal through Autocrine Activation of Soluble Guanylyl Cyclase
Alex C. Y. Chang et al.
DEVELOPMENTAL CELL (2011)
Role of intimate interactions between endothelial cells and the surrounding accessory cells in the maturation of blood vessels
N. Takakura
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Sema3E/Plexin-D1 Mediated Epithelial-to-Mesenchymal Transition in Ovarian Endometrioid Cancer
Chun-Hsien Tseng et al.
PLOS ONE (2011)
A Pericyte Origin of Spinal Cord Scar Tissue
Christian Goritz et al.
SCIENCE (2011)
Systemic sclerosis - A systematic overview Part 1-Disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance
P. Klein-Weigel et al.
VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE (2011)
Endothelial Fli1 Deficiency Impairs Vascular Homeostasis A Role in Scleroderma Vasculopathy
Yoshihide Asano et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis
Benjamin D. Humphreys et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Treatment With Rapamycin Prevents Fibrosis in Tight-Skin and Bleomycin-Induced Mouse Models of Systemic Sclerosis
Ayumi Yoshizaki et al.
ARTHRITIS AND RHEUMATISM (2010)
Targeting ADAM-17/Notch Signaling Abrogates the Development of Systemic Sclerosis in a Murine Model
Niloufar Kavian et al.
ARTHRITIS AND RHEUMATISM (2010)
Atherosclerosis and macrovascular involvement in systemic sclerosis: Myth or reality
Udi Nussinovitch et al.
AUTOIMMUNITY REVIEWS (2010)
Cellular and molecular aspects of vascular dysfunction in systemic sclerosis
Maria Trojanowska
NATURE REVIEWS RHEUMATOLOGY (2010)
Lung involvement in systemic sclerosis
Paul M. Hassoun
PRESSE MEDICALE (2010)
Connective tissue growth factor is induced in bleomycin-induced skin scleroderma
Shangxi Liu et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2010)
Scleroderma Renal Crisis: A Pathology Perspective
Ibrahim Batal et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2010)
Proliferation Signal Inhibitors for the Treatment of Refractory Autoimmune Rheumatic Diseases A New Therapeutic Option
Kam Hon Yoon
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY (2009)
Rapamycin Versus Methotrexate in Early Diffuse Systemic Sclerosis Results From a Randomized, Single-Blind Pilot Study
Tien-I Karleen Su et al.
ARTHRITIS AND RHEUMATISM (2009)
Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation
Amber N. Stratman et al.
BLOOD (2009)
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
M. J. Overbeek et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts
Estrella Garcia-Gonzalez et al.
RHEUMATOLOGY (2009)
Bone marrow Derived Pluripotent Cells are Pericytes which Contribute to Vascularization
Xiaoxiao Cai et al.
STEM CELL REVIEWS AND REPORTS (2009)
Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma
Agostino Di Ciaula et al.
BMC GASTROENTEROLOGY (2008)
Efficacy of Rapamycin in Scleroderma: A Case Study
Levi Fried et al.
Lymphatic Research and Biology (2008)
Differentiation of Bone Marrow Mesenchymal Stem Cells into the Smooth Muscle Lineage by Blocking ERK/MAPK Signaling Pathway
Kenichi Tamama et al.
STEM CELLS AND DEVELOPMENT (2008)
Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases
Peter Dorfmueller et al.
HUMAN PATHOLOGY (2007)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis
VS Rajkumar et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Share Paper
